Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset

By sjmartinez • March 8, 2024

Channick R, Chin KM, McLaughlin VV, Lammi MR, Zamanian RT, Turricchia S, Ong R, Mitchell L, Kim NH. Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset. Cardiol Ther. 2024 Mar 7. doi: 10.1007/s40119-024-00361-w. Epub ahead of print. PMID: 38451426.

Tags: Connective tissue disease, Macitentan, Mixed connective tissue disease, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, real-world evidence, Scleroderma, systemic lupus erythematosus, systemic sclerosis

Population risk predictors of major adverse kidney events attributed to focal segmental glomerulosclerosis from the CURE-CKD registry

Nicholas SB, Kornowske LM, Jones CR, Daratha KB, Alicic RZ, Reynolds CL, Neumiller JJ, Bensink ME, Gong W, Norris KC, Tuttle KR. Population risk predictors[...]

JPEN Journal Club 94. Qualitative systematic reviews

Koretz RL. JPEN Journal Club 94. Qualitative systematic reviews. JPEN J Parenter Enteral Nutr. 2025 Jul 18. doi: 10.1002/jpen.70000. Epub ahead of print. PMID: 40682300.

Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health Administration

Green-Lott AY, Wadhwa A, Bailey AV, Kwan L, Haroldsen CL, Shelton JB, Lewis MS, Beenhouwer DO, Chamie K, Rose BS, Maxwell KN, Nickols NG, Yamoah[...]